The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer

The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer

<p dir="ltr">Glucagon-like peptide-1 receptor (GLP-1R) agonists have garnered significant attention for their therapeutic potential in addressing the interconnected health challenges of diabetes, obesity, and cancer. The role of GLP-1R in type 2 diabetes mellitus (T2DM) is highlighte...

Full description

Saved in:
Bibliographic Details
Main Author: Shahad Sabaawi Ibrahim (21842273) (author)
Other Authors: Raghad Sabaawi Ibrahim (21842276) (author), Batoul Arabi (21842279) (author), Aranka Brockmueller (11064675) (author), Mehdi Shakibaei (325455) (author), Dietrich Büsselberg (11008857) (author)
Published: 2024
Subjects:
Biomedical and clinical sciences
Medical biochemistry and metabolomics
Nutrition and dietetics
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
Ozempic
Semaglutide
Cancer
Diabetes
Obesity
GLP1RA
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items